Inventor
ABEL DE LA ROSA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07HSugars23%
Y02ATechnologies for adaptation to climate change13%
C07BGeneral methods of organic chemistry10%
C07DHeterocyclic compounds10%
PatentTitleYear
12,595,280Phosphoramidates for the treatment of hepatitis B virus202612,414,961Substituted nucleosides and nucleotides for treating viral infections202511,981,699Phosphoramidates for the treatment of hepatitis B virus202411,857,560Pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections202411,447,518Phosphoramidates for the treatment of hepatitis B virus202211,364,257Phosphoramidates for the treatment of hepatitis B virus202211,192,914Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to UNIV EMORY (6)· patent assignee history
2021–2026Based in US· patent location history
2026Patents assigned to EMORY UNIV (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV EMORY | 6 | 2021–2025 |
| EMORY UNIV | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2026 |